Welcome to the official InxMed website

EN CN

LOGO

Press Release

Press Release

Home
>
History
>
Sep，2022
Company News Media Coverage  
News Center

Sep，2022

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2022-11-15 11:33
  • Views:

Sep，2022

  • Categories:History
  • Author:
  • Origin:
  • Time of issue:2022-11-15 11:33
  • Views:
Information

Announced first patient dosed in pivotal phase 2 study of IN10018 in PROC

Previous: Jun，2022
Next: Oct，2022
Previous: Jun，2022
Next: Oct，2022
office@inxmed.com
+86-10-85887500
+86-592-6537605
upspower1999
img
InxMed

We invent personalized medicines with global impact, and turn innovation in China to life saving therapies for the world

QUICK LINKS

About Us Our Science Pipeline Partnerships Press Release Join Us

CONTACT US

Tel: +86 25-58251030
Email: office@inxmed.com
Office address: 73 Tanmi Road Block D-2, 3rd Floor Jiangbei New District, Nanjing

MESSAGE

Follow Us：

img img

CopyRight © 2022 InxMed All Rights Reserved.

京ICP备19001572号-1
Powered by: 300.cn | SEO